InvestorsHub Logo
Followers 0
Posts 568
Boards Moderated 0
Alias Born 05/24/2013

Re: None

Sunday, 06/09/2013 10:19:16 AM

Sunday, June 09, 2013 10:19:16 AM

Post# of 297
AstraZeneca has been particularly aggressive recently as it tries to revive its pipeline, including agreeing last month to spend up to $443 million to acquire Omthera Pharmaceuticals (NASDAQ:OMTH) for its fish oil-based medicine in development. That move was on the heels of AstraZeneca buying early stage biotech company AlphaCore Pharma for an undisclosed amount in April.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AZN News